NASDAQ:TRIB Trinity Biotech - TRIB Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Trinity Biotech plc Please log in to your account or sign up in order to add this asset to your watchlist. $1.10 +0.02 (+1.86%) (As of 02/1/2023 12:00 AM ET) Add Compare Share Share Today's Range$1.05▼$1.1050-Day Range$0.96▼$1.3552-Week Range$0.86▼$1.55Volume7,909 shsAverage Volume21,043 shsMarket Capitalization$41.73 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Trinity Biotech MarketRank™ ForecastAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy0.16% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.96Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.71) to ($0.04) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.50 out of 5 starsMedical Sector950th out of 1,030 stocksDiagnostic Substances Industry14th out of 16 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Trinity Biotech. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.16% of the outstanding shares of Trinity Biotech have been sold short.Short Interest Ratio / Days to CoverTrinity Biotech has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Trinity Biotech has recently decreased by 19.84%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldTrinity Biotech does not currently pay a dividend.Dividend GrowthTrinity Biotech does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for TRIB. Previous Next 2.8 News and Social Media Coverage News SentimentTrinity Biotech has a news sentiment score of 0.96. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Trinity Biotech this week, compared to 0 articles on an average week. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Trinity Biotech insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 8.20% of the stock of Trinity Biotech is held by insiders.Percentage Held by InstitutionsOnly 18.41% of the stock of Trinity Biotech is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Trinity Biotech are expected to grow in the coming year, from ($0.71) to ($0.04) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Trinity Biotech is -1.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Trinity Biotech is -1.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here About Trinity Biotech (NASDAQ:TRIB) StockTrinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World geographical segments. The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland.Read More Receive TRIB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter. Email Address TRIB Stock News HeadlinesFebruary 2, 2023 | americanbankingnews.comTrinity Biotech (NASDAQ:TRIB) Now Covered by Analysts at StockNews.comJanuary 27, 2023 | americanbankingnews.comTrinity Biotech plc (NASDAQ:TRIB) Short Interest UpdateFebruary 2, 2023 | Investing Trends (Ad)The Biggest "Missing Ingredient" in the $7 Trillion EV MarketChina has owned the graphite market for decades. But the U.S. just added graphite to a list of super-critical minerals... "essential for America's National Defense." Perfect timing for a "made in America" graphite company looking to mine, manufacture, and recycle graphite for the booming electric car market.January 25, 2023 | americanbankingnews.comTrinity Biotech (NASDAQ:TRIB) Coverage Initiated by Analysts at StockNews.comJanuary 9, 2023 | wsj.comTrinity Biotech Announces Strategic Partnership with imaware(TM) to Deliver Integrated Diagnostic Testing Solutions to Digital Health IndustryJanuary 9, 2023 | finance.yahoo.comTrinity Biotech Announces Strategic Partnership with imaware™ to Deliver Integrated Diagnostic Testing Solutions to Digital Health IndustryDecember 23, 2022 | msn.comEuropean Equities Rise Modestly in Friday Trading, End Week Up 1%December 22, 2022 | finance.yahoo.comTrinity Biotech plc (NASDAQ:TRIB) Q2 2022 Earnings Call TranscriptFebruary 2, 2023 | Investing Trends (Ad)Profit From the Commercial Solar Boom?Solar energy had its best year ever in 2021, with a record 24 gigawatts of power installed. That's enough to power 18 million homes! Analysts expect the global solar farm market to reach $356 billion by 2028. The utility segment of the solar market is expected to grow at the highest annual growth rate in the industry, especially with the many tax incentives now offered. December 22, 2022 | finance.yahoo.comTrinity Biotech plc (NASDAQ:TRIB) Q3 2022 Earnings Call TranscriptDecember 16, 2022 | markets.businessinsider.comHere's what Wall Street expects from Trinity Biotech's earningsDecember 15, 2022 | seekingalpha.comTrinity Biotech plc (TRIB) Q3 2022 Earnings Call TranscriptDecember 15, 2022 | finance.yahoo.comTrinity Biotech Announces Q3 2022 Financial ResultsDecember 14, 2022 | msn.comTrinity Biotech's Earnings: A PreviewDecember 9, 2022 | finance.yahoo.comTrinity Biotech plc to Announce Third Quarter Fiscal Year 2022 Financial ResultsDecember 9, 2022 | finance.yahoo.comTrinity Biotech plc to Announce Third Quarter Fiscal Year 2022 Financial ResultsDecember 8, 2022 | msn.comPharma, Tech Sectors Help Buoy American Depositary Receipts of European StocksDecember 7, 2022 | msn.comPharama Stocks Nudge European Equities Modestly Higher in Wednesday TradingNovember 21, 2022 | msn.comRising COVID Cases in China, Plunging Oil Prices Drag European Equities Lower in Monday TradingNovember 3, 2022 | finance.yahoo.comTrinity Biotech Announces Quarter 2 2022 Financial Results And Preliminary Q3 2022 Revenue GuidanceNovember 1, 2022 | finance.yahoo.comTrinity Biotech plc to Announce Second Quarter Fiscal Year 2022 Financial ResultsOctober 26, 2022 | finance.yahoo.comTrinity Biotech Announces the Appointment of Tom Lindsay to its Board of DirectorsOctober 3, 2022 | benzinga.comTrinity Industries, Inc. Announces $1.8B Multi-Year Railcar OrderOctober 3, 2022 | finance.yahoo.comTrinity Biotech Announces The Appointment of Aris Kekedjian As Chairman and CEOOctober 1, 2022 | seekingalpha.comTRIB Trinity Biotech plcSeptember 30, 2022 | finance.yahoo.comTrinity Biotech Announces Results of AGMAugust 28, 2022 | finance.yahoo.comIs There Now An Opportunity In Trinity Biotech plc (NASDAQ:TRIB)?See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive TRIB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter. Email Address TRIB Company Calendar Last Earnings12/15/2022Today2/02/2023Next Earnings (Estimated)4/10/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Diagnostic substances Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:TRIB CUSIPN/A CIK888721 Webwww.trinitybiotech.com Phone(531) 276-9800Fax353-1276-9888Employees543Year Founded1992Profitability EPS (Most Recent Fiscal Year)($1.09) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$880,000.00 Net Margins-42.21% Pretax Margin-30.60% Return on Equity-419.23% Return on Assets-15.45% Debt Debt-to-Equity Ratio8.70 Current Ratio3.38 Quick Ratio1.78 Sales & Book Value Annual Sales$92.96 million Price / Sales0.45 Cash Flow$0.58 per share Price / Cash Flow1.89 Book Value($0.02) per share Price / Book-54.75Miscellaneous Outstanding Shares38,110,000Free Float34,983,000Market Cap$41.73 million OptionableOptionable Beta1.42 Social Links Key ExecutivesAris KekedjianChairman & Chief Executive OfficerJohn GillardCFO, Secretary & Executive DirectorEibhlin KellyChief Information OfficerTerence DunneDirector-Business DevelopmentFernando DeviaExecutive Vice President-SalesKey CompetitorsNymox PharmaceuticalNASDAQ:NYMXBiomericaNASDAQ:BMRAARCA biopharmaNASDAQ:ABIOOncoCyteNASDAQ:OCXImmuCellNASDAQ:ICCCView All CompetitorsInsiders & InstitutionsHunter Associates Investment Management LLCBought 26,443 shares on 2/1/2023Ownership: 4.785%Renaissance Technologies LLCSold 65,098 shares on 11/14/2022Ownership: 3.774%View All Institutional Transactions TRIB Stock - Frequently Asked Questions How have TRIB shares performed in 2023? Trinity Biotech's stock was trading at $0.99 on January 1st, 2023. Since then, TRIB shares have increased by 10.6% and is now trading at $1.0950. View the best growth stocks for 2023 here. Are investors shorting Trinity Biotech? Trinity Biotech saw a decline in short interest in the month of January. As of January 15th, there was short interest totaling 60,600 shares, a decline of 19.8% from the December 31st total of 75,600 shares. Based on an average trading volume of 33,600 shares, the days-to-cover ratio is currently 1.8 days. View Trinity Biotech's Short Interest. When is Trinity Biotech's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, April 10th 2023. View our TRIB earnings forecast. How were Trinity Biotech's earnings last quarter? Trinity Biotech plc (NASDAQ:TRIB) posted its quarterly earnings data on Thursday, December, 15th. The company reported ($0.18) earnings per share for the quarter, missing the consensus estimate of ($0.04) by $0.14. The business had revenue of $19.50 million for the quarter, compared to analysts' expectations of $19.50 million. Trinity Biotech had a negative trailing twelve-month return on equity of 419.23% and a negative net margin of 42.21%. What guidance has Trinity Biotech issued on next quarter's earnings? Trinity Biotech updated its third quarter 2022 earnings guidance on Thursday, November, 10th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $19.00 million-$20.00 million. What is Ronan O'Caoimh's approval rating as Trinity Biotech's CEO? 20 employees have rated Trinity Biotech Chief Executive Officer Ronan O'Caoimh on Glassdoor.com. Ronan O'Caoimh has an approval rating of 8% among the company's employees. This puts Ronan O'Caoimh in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Trinity Biotech own? Based on aggregate information from My MarketBeat watchlists, some companies that other Trinity Biotech investors own include Gilead Sciences (GILD), Novavax (NVAX), OPKO Health (OPK), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Netflix (NFLX), Pfizer (PFE), QUALCOMM (QCOM), Energy Transfer (ET) and Exxon Mobil (XOM). What is Trinity Biotech's stock symbol? Trinity Biotech trades on the NASDAQ under the ticker symbol "TRIB." Who are Trinity Biotech's major shareholders? Trinity Biotech's stock is owned by a number of institutional and retail investors. Top institutional investors include Hunter Associates Investment Management LLC (4.79%) and Concourse Financial Group Securities Inc. (0.00%). How do I buy shares of Trinity Biotech? Shares of TRIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Trinity Biotech's stock price today? One share of TRIB stock can currently be purchased for approximately $1.10. How much money does Trinity Biotech make? Trinity Biotech (NASDAQ:TRIB) has a market capitalization of $41.73 million and generates $92.96 million in revenue each year. The company earns $880,000.00 in net income (profit) each year or ($1.09) on an earnings per share basis. How many employees does Trinity Biotech have? The company employs 543 workers across the globe. How can I contact Trinity Biotech? Trinity Biotech's mailing address is IDA BUSINESS PARK BRAY, WICKLOW L2, . The official website for the company is www.trinitybiotech.com. The company can be reached via phone at (531) 276-9800, via email at kevin.tansley@trinitybiotech.com, or via fax at 353-1276-9888. This page (NASDAQ:TRIB) was last updated on 2/2/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.